Asivatrep
CAS No. 1005168-10-4
Asivatrep ( PAC-14028;PAC14028 )
Catalog No. M10042 CAS No. 1005168-10-4
Asivatrep (PAC-14028) is a potent, selective TRPV1 antagonist with IC50 of 55 nM against capsaicin-induced Ca2+ influx in rat DRG neurons.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 312 | Get Quote |
|
50MG | 1341 | Get Quote |
|
100MG | 1791 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAsivatrep
-
NoteResearch use only, not for human use.
-
Brief DescriptionAsivatrep (PAC-14028) is a potent, selective TRPV1 antagonist with IC50 of 55 nM against capsaicin-induced Ca2+ influx in rat DRG neurons.
-
DescriptionAsivatrep (PAC-14028) is a potent, selective TRPV1 antagonist with IC50 of 55 nM against capsaicin-induced Ca2+ influx in rat DRG neurons, does not inhibit or activate other TRP channels such as hTRPV2, hTRPV3, hTRPM8 and hTRPA1; inhibits capsaicin-evoked calcium influx in keratinocytes at sub-micromolar concentrations, blocks capsaicin-induced blood perfusion increase, and the accelerated barrier recovery from tape-stripping-induced barrier damages in hairless mice, also attenuates dermatitis-associated barrier damages in Df and OXZ models.Dermatitis Phase 3 Clinical
-
SynonymsPAC-14028;PAC14028
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research AreaInflammation/Immunology
-
IndicationDermatitis
Chemical Information
-
CAS Number1005168-10-4
-
Formula Weight491.47
-
Molecular FormulaC21H22F5N3O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 28 mg/mL
-
SMILESO=C(N[C@@H](C1=CC(F)=C(NS(=O)(C)=O)C(F)=C1)C)/C=C/C2=CC=C(C(F)(F)F)N=C2CCC
-
Chemical Name2-Propenamide, N-[(1R)-1-[3,5-difluoro-4-[(methylsulfonyl)amino]phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)-3-pyridinyl]-, (2E)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yun JW, et al. J Dermatol Sci. 2011 Apr;62(1):8-15.
2. Yun JW, et al. J Invest Dermatol. 2011 Jul;131(7):1576-9.
3. Lim KM, et al. Arch Pharm Res. 2012 Mar;35(3):393-6.
2. Yun JW, et al. J Invest Dermatol. 2011 Jul;131(7):1576-9.
3. Lim KM, et al. Arch Pharm Res. 2012 Mar;35(3):393-6.
molnova catalog
related products
-
Linoleoyl Ethanolami...
Linoleoyl Ethanolamide is an endocannabinoid agent.?It acts by binding to TRPV1 increasing ERK phosphorylation and AP-1 dependent transcription in CB-receptor in an independent manner.
-
LASSBio-1135
LASSBio-1135 is an orally effective antagonist of TRPV1 and inhibitor of TNF-α production.Oral administration of 100 mol x Kg(-1) LASSBio-1135 markedly reduced thermal hyperalgesia induced by carrageenan.
-
GSK2193874
GSK2193874 was identified as a selective orally active TRPV4 blocker.